Clinical Trial Results:
An open-label, long term (52 week) extension study to evaluate the safety, tolerability, and efficacy of treatment with LCZ696 monotherapy and LCZ696 in combination with amlodipine in patients with essential hypertension
Summary
|
|
EudraCT number |
2013-002306-31 |
Trial protocol |
SK ES |
Global completion date |
02 Jul 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
02 Dec 2019
|
First version publication date |
06 Feb 2019
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
cancellation letter for CLCZ696A2301E1 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.